Genus plc (GNS) Lifted to “Buy” at N+1 Singer
Genus plc (LON:GNS) was upgraded by analysts at N+1 Singer to a “buy” rating in a research note issued to investors on Monday. The brokerage presently has a GBX 2,485 ($32.79) target price on the stock, up from their prior target price of GBX 1,844 ($24.33). N+1 Singer’s target price points to a potential upside of 11.19% from the stock’s current price.
A number of other brokerages have also recently commented on GNS. Peel Hunt restated a “buy” rating and set a GBX 2,600 ($34.31) price target on shares of Genus plc in a research note on Monday, October 9th. Liberum Capital restated a “hold” rating and set a GBX 2,100 ($27.71) price target on shares of Genus plc in a research note on Monday, October 9th. Finally, Numis Securities Ltd restated a “hold” rating and set a GBX 1,815 ($23.95) price target on shares of Genus plc in a research note on Thursday, September 7th. Three equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Genus plc currently has an average rating of “Hold” and an average target price of GBX 2,250 ($29.69).
Genus plc (LON:GNS) traded up 7.79% on Monday, reaching GBX 2409.00. 60,287 shares of the company’s stock traded hands. The stock’s market cap is GBX 1.47 billion. Genus plc has a 52-week low of GBX 1,652.00 and a 52-week high of GBX 2,421.00. The company’s 50 day moving average is GBX 2,111.62 and its 200-day moving average is GBX 1,883.54.
TRADEMARK VIOLATION NOTICE: This piece of content was first reported by American Banking News and is the sole property of of American Banking News. If you are viewing this piece of content on another domain, it was illegally stolen and reposted in violation of United States and international copyright & trademark laws. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/10/30/genus-plc-gns-lifted-to-buy-at-n1-singer.html.
Genus plc Company Profile
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
Receive News & Ratings for Genus plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus plc and related companies with MarketBeat.com's FREE daily email newsletter.